-+ 0.00%
-+ 0.00%
-+ 0.00%

Wantai Biotech (603392.SH): Freeze-dried recombinant respiratory syncytial virus vaccine (CHO cells) approved for clinical trials

Zhitongcaijing·10/12/2026 08:09:05
Listen to the news

Zhitong Finance App News, Wantai Biotech (603392.SH) issued an announcement. Recently, Wan Tai Canghai, a wholly-owned subsidiary of the company, received the “Drug Clinical Trial Approval Notice” for the freeze-dried recombinant respiratory syncytial virus vaccine (CHO cells) approved and issued by the State Drug Administration. It was agreed to conduct clinical trials to prevent lower respiratory diseases caused by respiratory syncytial virus (RSV) infection in people aged 60 and above.